Drugs Made In America Acquisition Corp. Files Q1 2025 10-Q

Ticker: DMAAR · Form: 10-Q · Filed: May 20, 2025 · CIK: 2028614

Drugs Made In America Acquisition Corp. 10-Q Filing Summary
FieldDetail
CompanyDrugs Made In America Acquisition Corp. (DMAAR)
Form Type10-Q
Filed DateMay 20, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, filing

TL;DR

**DMAA files Q1 10-Q. Financials out May 20, 2025.**

AI Summary

Drugs Made In America Acquisition Corp. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in the Cayman Islands, is headquartered in Fort Lauderdale, Florida, with a business phone number of (954) 870-3099. The filing was made on May 20, 2025, under SEC file number 001-42467.

Why It Matters

This filing provides investors with an update on the company's financial performance and operational status for the first quarter of 2025.

Risk Assessment

Risk Level: low — This is a routine quarterly filing and does not contain immediate, significant risk-inducing information.

Key Numbers

  • 001-42467 — SEC File Number (Identifies the company's filings with the SEC.)
  • March 31, 2025 — Quarter End Date (Marks the end of the reporting period for this 10-Q.)
  • May 20, 2025 — Filing Date (The date the report was officially submitted to the SEC.)

Key Players & Entities

  • Drugs Made In America Acquisition Corp. (company) — Registrant
  • March 31, 2025 (date) — Quarterly period end date
  • May 20, 2025 (date) — Filing date
  • 001-42467 (dollar_amount) — SEC File Number
  • Fort Lauderdale, FL (company) — Principal executive offices location

FAQ

What is the exact fiscal year end for Drugs Made In America Acquisition Corp.?

The fiscal year end for Drugs Made In America Acquisition Corp. is December 31.

What is the principal executive office address for the company?

The principal executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301.

What is the company's telephone number?

The company's telephone number is (954) 870-3099.

In which jurisdiction was Drugs Made In America Acquisition Corp. incorporated?

The company was incorporated in the Cayman Islands.

What is the SIC code listed for this company?

The Standard Industrial Classification (SIC) code listed is 6770 for BLANK CHECKS.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding Drugs Made In America Acquisition Corp. (DMAAR).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.